A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy
Clinical trial NCT05669638 · UNKNOWN
Trial details
- NCT number
- NCT05669638
- Sponsor
- Xuanwu Hospital, Beijing
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-01
- Primary completion
- 2025-05-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.